Skip to main content Accesibility Help
×
×
Home

The Differential Diagnosis of Pseudobulbar Affect (PBA): Distinguishing PBA Among Disorders of Mood and Affect

  • David B. Arciniegas (a1), Edward C. Lauterbach (a2), David L. Ginsberg, Karen E. Anderson (a3), Tiffany W. Chow (a4), Laura A. Flashman (a5), Robin A. Hurley (a6), Daniel I. Kaufer (a7), Thomas W. McAllister (a8), Alison Reeve (a9), Randolph B. Schiffer (a10) and Jonathan M. Silver (a11)...
Abstract

This monograph summarizes the proceedings of a roundtable meeting convened to discuss pseudobulbar affect (PBA). Two didactic lectures were presented, followed by a moderated discussion among 11 participants. Post-meeting manuscript development synthesized didactic- and discussion-based content and incorporated additional material from the neuroscience literature. A conceptual framework with which to distinguish between disorders of mood and affect is presented first, and disorders of affect regulation are then reviewed briefly. A detailed description of the most common of these disorders, PBA, is the focus of the remainder of the monograph. The prevalence, putative neuranatomic and neurochemical bases of PBA are reviewed, and current and emerging methods of evaluation and treatment of persons with PBA are discussed. The material presented in this monograph will help clinicians better recognize, diagnose, and treat PBA, and will form a foundation for understanding and interpreting future studies of this condition.

Copyright
Corresponding author
David B. Arciniegas, MD, Neuropsychiatry Service, University of Colorado School of Medicine, Campus Box C268-25, 4200 East Ninth Ave, Denver, CO 80211; Tel: 303-315-5365; Fax:, 303-315-5641; E-mail:, David.Arciniegas@UCHSC.edu
References
Hide All
1.Dark, FL, McGrath, JJ, Ron, MA. Pathological laughing and crying. Aust N Z J Psychiatry. 1996;30(4):472479.
2.Green, RL. Regulation of affect. Semin Clin Neuropsychiatry. 1998;3(3):195200.
3.Poeck, K. Pathological laughing and weeping in patients with progressive bulbar palsy. Ger Med Mon. 1969;14(8):394397.
4.Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. Washington, DC: American Psychiatric Association; 1987.
5.Arciniegas, DB, Topkoff, J. The neuropsychiatry of pathologic affect: an approach to evaluation and treatment. Semin Clin Neuropsychiatry. 2000;5(4):290306.
6.Wilson, SAK. Some problems in neurology. II. Pathological laughing and crying. J Neurol Psychopathol. 1924;4:299333.
7.Poeck, K. Pathological laughter and crying. In: Fredericks, JAM, ed. Handbook of Clinical Neurology. Vol 45. Amsterdam, Netherlands: Elsevier Science Publishers; 1985.
8.Green, RL, Bernat, JL. Pathologic crying. In: Joseph, AB, Young, RR, eds. Movement disorders in Neurology and Neuropsychiatry. Oxford, UK: Blackwell Science, Inc; 1999.
9.Carota, A, Berney, A, Aybek, S, et al.A prospective study of predictors of poststroke depression. Neurology. 2005;64(3):428433.
10.Woyshville, MJ, Lackamp, JM, Eisengart, JA, Gilliland, JA. On the meaning and measurement of affective instability: clues from chaos theory. Biol Psychiatry. 1999;45(3):261269.
11.Moore, SR, Gresham, LS, Bromberg, MB, Kasarkis, EJ, Smith, RA. A self report measure of affective lability. J Neurol Neurosurg Psychiatry. 1997;63(1):8993.
12.Feinstein, A, Feinstein, K, Gray, T, O'Connor, P. Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol. 1997;54(9):11161121.
13.Green, RL, McAllister, TW, Bernat, JL. A study of crying in medically and surgically hospitalized patients. Am J Psychiatry. 1987;144(4):442447.
14.Berkovic, SF, Andermann, F. Pathological laughing. In: Joseph, AB, Young, RR, eds. Movement Disorders in Neurology and Neuropsychiatry. Oxford, UK: Blackwell Science, Inc; 1999.
15.Duchowny, MS. Pathological disorders of laughter. In: McGhee, PE, Goldstein, JH, eds. Handbook of Human Research. Vol II. New York, NY: Springer-Verlag; 1983.
16.Trimble, MR, Mendez, MF, Cummings, JL. Neuropsychiatric symptoms from the temporolimbic lobes. J Neuropsychiatry Clin Neurosci. 1997;9(3):429438.
17.Bucy, PC, Klüver, H. An anatomical investigation of the temporal lobe in the monkey (Macaca mulatta). J Comp Neurol. 1955;103(2):151251.
18.Garg, RK, Misra, S, Verma, R. Pathological laughter as heralding manifestation of left middle cerebral artery territory infarct: case report and review of literature. Neurol India. 2000;48(4):388390.
19.Mukand, J, Kaplan, M, Senno, RG, Bishop, DS. Pathological crying and laughing: treatment with sertraline. Arch Phys Med Rehabil. 1996;77(12):13091311.
20.Wild, B, Rodden, FA, Grodd, W, Ruch, W. Neural correlates of laughter and humour. Brain. 2003;126(Pt 10):21212138.
21.Hopf, HC, Muller-Forell, W, Hopf, NJ. Localization of emotional and volitional facial paresis. Neurology. 1992;42(10):19181923.
22.Munschauer, FE, Mador, MJ, Ahuja, A, Jacobs, L. Selective paralysis of voluntary but not limbically influenced automatic respiration. Arch Neurol. 1991;48(11):11901192.
23.Arroyo, S, Lesser, RP, Gordon, B, et al.Mirth, laughter and gelastic seizures. Brain. 1993;116(Pt 4):757780.
24.Foerster, O, Gagel, O. Ein Beltrag zur Frage der Bezlehungen psychischer Storungen Hirnstamm. Z ges Neurol Psychiatr. 1933;149:312.
25.Bard, P. The neuro-humoral basis of emotional reactions. In: Murchison, C. Handbook of General Experimental Psychology. Worcester, MA: Clark University Press; 1934:264311.
26.Hermann, C, Brown, IW. Palatal myoclonus: a reappraisal. J Neurol Sci. 1967;5:473492.
27.Parvizi, J, Anderson, SW, Martin, CO, Damasio, H, Damasio, AR. Pathological laughter and crying: a link to the cerebellum. Brain. 2001;124(Pt 9):17081719.
28.Riggs, JE, Schochet, SS Jr, Hogg, JP. Delayed diffuse upper motor neuron syndrome after compressive thoracic myelopathy. Mil Med. 1999;164(9):666668.
29.Poeck, K. Pathological laughter and crying. In: Vinken, PJ, Bruyn, GW, Klawans, HV, eds. Handbook of Clinical Neurology. Vol 1 (45). Amsterdam, Netherlands: Elsevier; 1985:219225.
30.Lane, RD, Reiman, EM, Ahern, GL, Schwartz, GE, Davidson, RJ. Neuroanatomical correlates of happiness, sadness, and disgust. Am J Psychiatry. 1997;154(7):926933.
31.Martin, JH. Neuroanatomy Text and Atlas. New York, NY: Elsevier; 1989.
32.Andersen, G, Ingeman-Nielsen, M, Vestergaard, K, Riis, JO. Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke. 1994;25(5):10501052.
33.Brown, JW. Physiology and phylogenesis of emotional expression. Brain Res. 1967;5(1):114.
34.Kelly, A, Beaton, LE, Magoun, HW. Midbrain mechanism for facio-vocal activity J Neurophysiol. 1946;8:181189.
35.Holstege, G. The emotional motor system. Eur J Morphol. 1992;30(1):6779.
36.Ironside, R. Disorders oflaughter due to brain lesions. Brain. 1956;79(4):589609.
37.McCullagh, S, Moore, M, Gawel, M, Feinstein, A. Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci. 1999;169(1-2):4348.
38.Kim, JS, Choi-Kwon, S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology. 2000;54(9):18051810.
39.Okun, MS, Raju, DV, Walter, BL, et al.Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus. J Neurol Neurosurg Psychiatry. 2004; 75(6):921923.
40.Schmahmann, JD, Ko, R, MacMore, J. The human basis pontis: motor syndromes and topographic organization. Brain. 2004;127(Pt 6):12691291.
41.Kataoka, S, Hori, A, Shirakawa, T, Hirose, G. Paramedian pontine infarction. Neurological/topographical correlation. Stroke. 1997;28(4):809815.
42.Achari, AN, Colover, J. Posterior fossa tumors with pathological laughter. JAMA. 1976;235(14):14691471.
43.Doorenbos, DI, Haerer, AF, Payment, M, Clifton, ER. Stimulus-specific pathologic laughter: a case report with discrete unilateral localization. Neurology. 1993;43(1):229230.
44.Lauterbach, EC, Price, ST, Spears, TE, Jackson, JG, Kirsh, AD. Serotonin responsive and nonresponsive diurnal depressive mood disorders and pathological affect in thalamic infarct associated with myoclonus and blepharospasm. Biol Psychiatry. 1994;35(7):488490.
45.Kuzniecky, R, Guthrie, B, Mountz, J, et al.Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol. 1997;42(1):6067.
46.Sackeim, HA, Greenberg, MS, Weiman, AL, Gur, RC, Hungerbuhler, JP, Geschwind, N. Hemispheric asymmetry in the expression of positive and negative emotions. Neurologic evidence. Arch Neurol. 1982;39(4):210218.
47.Lauterbach, EC, Schweri, MM. Amelioration of pseudobulbar affect by fluoxetine: possible alteration of dopamine-related pathophysiology by a selective serotonin reuptake inhibitor. J Clin Psychopharmacol. 1991;11(6):392393.
48.Brooks, BR, Thisted, RA, Appel, SH, et al.Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004;63(8):13641370.
49.Derex, L, Ostrowsky, K, Nighoghossian, N, Trouillas, P. Severe pathological crying after left anterior choroidal artery infarct. Reversibility with paroxetine treatment. Stroke. 1997;28(7):14641466.
50.Murai, T, Barthel, H, Berrouschot, J, Sorger, D, von Cramon, DY, Muller, U. Neuroimaging of serotonin transporters in post-stroke pathological crying. Psychiatry Res. 2003;123(3):207211.
51.Klein, M, Musacchio, JM. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J Pharmacol Exp Ther. 1989;251(1):207215.
52.Tortella, FC, Pellicano, M, Bowery, NG. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci. 1989;10(12):501507.
53.Bermack, JE, Debonnel, G. The role of sigma receptors in depression. J Pharmacol Sci. 2005; 97(3):317336.
54.Yamamoto, H, Yamamoto, T, Sagi, N, et al.Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site. J Neurosci. 1995;15(1 Pt 2):731736.
55.Rogawski, MA. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerability. Amino Acids. 2000;19(1):133149.
56.Robinson, RG, Parikh, RM, Lipsey, JR, Starkstein, SE, Price, TR. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry. 1993;150(2):286293.
57.Newsom-Davis, IC, Abrahams, S, Goldstein, LH, Leigh, PN. The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci. 1999;169(1-2):2225.
58.Harvey, PD, Greenberg, BR, Serper, MR. The affective lability scales: development, reliability, and validity. J Clin Psychol. 1989;45(5):786793.
59.Sloan, RL, Brown, KW, Pentland, B. Fluoxetine as a treatment for emotional lability after brain injury. Brain Inj. 1992; 6(4):315319.
60.Smith, RA, Berg, JE, Pope, LE, Callahan, JD, Wynn, D, Thisted, RA. Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. Mult Scler. 2004;10(6):679685.
61.Szczudlik, A, Slowik, A, Tomik, B. The effect of amitriptyline on the pathological crying and other pseudobulbar signs. Neurol Neurochir Pol. 1995;29(5):663674.
62.Schiffer, RB, Herndon, RM, Rudick, RA. Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med. 1985;312(23):14801482.
63.Andersen, G, Vestergaard, K, Riis, JO. Citalopram for post-stroke pathological crying. Lancet. 1993;342:837839.
64.Lawson, IR, MacLeod, RD. The use of imipramine (“Tofranil”) and other psychotropic drugs in organic emotionalism. Br J Psychiatry. 1969;115(520):281285.
65.Burns, A, Russell, E, Stratton-Powell, H, Tyrell, P, O'Neill, P, Baldwin, R. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry. 1999;14(8):681685.
66.Nahas, Z, Arlinghaus, KA, Kotrla, KJ, Clearman, RR, George, MS. Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. J Neuropsychiatry Clin Neurosci. 1998;10(4):453455.
67.Müller, U, Murai, T, Bauer-Wittmund, T, von Cramon, DY. Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Inj. 1999;13(10):805811.
68.Maurice, T, Urani, A, Phan, VL, Romieu, P. The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Brain Res Rev. 2001;37(1-3):116132.
69.Choi, DW, Peters, S, Viseskul, V. Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons. J Pharmacol Exp Ther. 1987;242(2):713720.
70.Chapman, AG, Meldrum, BS. Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur J Pharmacol. 1989; 18;166(2):201211.
71.Clement, HW, Grote, C, Svensson, L, Engel, J, Zofel, P, Wesemann, W. In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat. J Neural Transm Suppl. 1995;46:107–15.
72.Bubser, M, Keseberg, U, Notz, PK, Schmidt, WJ. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol. 1992; 8:229(1):7582.
73.Moresco, RM, Volonte, MA, Messa, C, et al.New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: a PET - [(11)C]raclopride study. J Neural Transm. 2002;109(10):12651274.
74.Kim, HS, Park, IS, Lim, HK, Choi, HS. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice. Arch Pharm Res. 1999;22(2):113118.
75.Kim, HS, Park, IS, Park, WK. NMDA receptor antagonists enhance 5-HT2receptor-mediated behavior, head-twitch response, in mice. Life Sci. 1998;63(26):23052311.
76.Meoni, P, Tortella, FC, Bowery, NG. An autoradiographic study of dextromethorphan high-affinity binding sites in rat brain: sodium-dependency and colocalization with paroxetine. Br J Pharmacol. 1997;120(7):12551262.
77.Nemeroff, CB. Recent advances in the neurobiology of depression. Psychopharmacol Bull. 2002;36(Suppl 2):623.
78.Henn, FA, Vollmayr, B. Basic pathophysiological mechanisms in depression: what are they and how might they affect the course of the illness? Pharmacopsychiatry. 2004;37(suppl 2):S152156.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed